低剂量计算机断层扫描中迭代重建对弥漫性间质性肺疾病评估的影响
研究通过体模和23例患者回顾性比较低剂量CT中滤波反投影、自适应统计迭代重建(ASIR)与基于模型的迭代重建(MBIR)对弥漫性间质性肺疾病的评估影响。结果显示各重建方法对疾病存在检测的AUC相似(0.963–0.979),但低剂量CT各重建方法较超高清CT倾向于低估网状或蜂窝状影、高估磨玻璃影,重建方法间影像诊断无差异。作者结论认为典型病例中MBIR低剂量CT诊断效能与超高清CT相似,但比较病变范围时需谨慎,尤其在随访研究中。
要点
- 低剂量CT各重建方法对弥漫性间质性肺疾病存在检测的AUC为0.963–0.979,与超高清CT相似。
- 低剂量CT的FBP、ASIR和MBIR较超高清CT分别低估网状或蜂窝状影2.8%、4.1%和5.3%。
- 低剂量CT的FBP、ASIR和MBIR较超高清CT分别高估磨玻璃影4.6%、8.9%和8.5%。
核心结论
- 典型弥漫性间质性肺疾病病例中,MBIR低剂量CT诊断效能与超高清CT相似;但比较病变范围时需谨慎,尤其在采用迭代重建的随访研究中。
研究设计与样本
- 体模研究使用ACR体模模块4在120 kVp下以10–100有效mAs扫描,比较FBP、ASIR(混合比0%、30%、70%、100%)和MBIR的空间分辨率;患者研究为前瞻性采集数据的回顾性解读,经机构审查委员会批准,纳入23例患者(平均年龄64岁),在120 kVp下分别行标准剂量方案(142–275 mA伴剂量调制,超高清CT)和低剂量方案(20 mA,低剂量CT),超高清CT图像用FBP重建,低剂量CT图像用FBP、ASIR和MBIR重建,由胸部放射科医生独立随机阅片。
关键影像表现/征象
- 体模研究中ASIR空间分辨率与FBP相当,MBIR在10 mA下空间分辨率明显下降;患者研究中疾病存在检测无显著差异,各重建方法间放射学诊断无差异。
诊断标准与关键数值
- 以超高清CT为参考,低剂量CT各重建方法检测弥漫性间质性肺疾病的AUC分别为FBP 0.979、ASIR 0.972、MBIR 0.963,超高清CT为0.978;病变范围以最近5%肺实质受累进行半定量比较。
临床应用与阅片要点
- 低剂量CT的FBP、ASIR和MBIR较超高清CT分别低估网状或蜂窝状影2.8%、4.1%和5.3%,分别高估磨玻璃影4.6%、8.9%和8.5%;各重建方法间放射学诊断无差异,但比较病变范围时需谨慎,尤其在采用迭代重建的随访研究中。
局限性
- 患者研究基于前瞻性采集数据的回顾性解读。
- 样本量为23例患者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: To evaluate the impact of iterative reconstruction (IR) on the assessment of diffuse interstitial lung disease (DILD) using CT.
MATERIALS AND METHODS: An American College of Radiology (ACR) phantom (module 4 to assess spatial resolution) was scanned with 10-100 effective mAs at 120 kVp. The images were reconstructed using filtered back projection (FBP), adaptive statistical iterative reconstruction (ASIR), with blending ratios of 0%, 30%, 70% and 100%, and model-based iterative reconstruction (MBIR), and their spatial resolution was objectively assessed by the line pair structure method. The patient study was based on retrospective interpretation of prospectively acquired data, and it was approved by the institutional review board. Chest CT scans of 23 patients (mean age 64 years) were performed at 120 kVp using 1) standard dose protocol applying 142-275 mA with dose modulation (high-resolution computed tomography [HRCT]) and 2) low-dose protocol applying 20 mA (low dose CT, LDCT). HRCT images were reconstructed with FBP, and LDCT images were reconstructed using FBP, ASIR, and MBIR. Matching images were randomized and independently reviewed by chest radiologists. Subjective assessment of disease presence and radiological diagnosis was made on a 10-point scale. In addition, semi-quantitative results were compared for the extent of abnormalities estimated to the nearest 5% of parenchymal involvement.
RESULTS: In the phantom study, ASIR was comparable to FBP in terms of spatial resolution. However, for MBIR, the spatial resolution was greatly decreased under 10 mA. In the patient study, the detection of the presence of disease was not significantly different. The values for area under the curve for detection of DILD by HRCT, FBP, ASIR, and MBIR were as follows: 0.978, 0.979, 0.972, and 0.963. LDCT images reconstructed with FBP, ASIR, and MBIR tended to underestimate reticular or honeycombing opacities (-2.8%, -4.1%, and -5.3%, respectively) and overestimate ground glass opacities (+4.6%, +8.9%, and +8.5%, respectively) compared to the HRCT images. However, the reconstruction methods did not differ with respect to radiologic diagnosis.
CONCLUSION: The diagnostic performance of LDCT with MBIR was similar to that of HRCT in typical DILD cases. However, caution should be exercised when comparing disease extent, especially in follow-up studies with IR.
引用
- Lim HJ, Chung MJ, Shin KE, et al. The Impact of Iterative Reconstruction in Low-Dose Computed Tomography on the Evaluation of Diffuse Interstitial Lung Disease. Korean J Radiol. 2016. PMID: 27833411
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。